
Retatrutide 4-Vial Bundle
The Retatrutide 4-Vial Bundle, in stock now, contains four sealed 10 mg vials and nothing else, with no bacteriostatic water and no syringes. Australian Research Peptides packs it in Australia for laboratories and researchers who already have their own supplies. Retatrutide, a 39-amino-acid peptide, is studied in metabolic research for its reported activity at three receptors: GIP, GLP-1 and glucagon. That is forty milligrams in total, HPLC-tested and posted to any state or territory. Supplied for in vitro research purposes only.
Includes 4 × Retatrutide 10 mg
Free Express Post on any order with a bundle in it — the whole order, not just the bundle.
About Retatrutide 4-Vial Bundle
The Retatrutide 4-Vial Bundle is a kit of four identical items: four 10 mg Retatrutide vials. There is no bacteriostatic water in it and no syringe pack. Each vial arrives sealed, exactly as it would if bought on its own, so the bundle is simply a way of buying the same product four times rather than a new fifth product.
This bundle exists because the other two Retatrutide kits are built for a different buyer. The Value Bundle and the Mega Bundle both pair the vials with the diluent and syringes a freeze-dried peptide needs before lab work can begin, which suits a lab that has neither. A lab that already has both would be buying them twice. This listing is the peptide on its own for that buyer, and it is the only bundle in the catalogue built that way.
Choosing four vials is simply about quantity. The milligram figure on each label is the peptide weight, so four 10 mg vials hold 40 mg in total, and splitting that across four sealed vials rather than one larger one means only the vial in use is ever opened. Bacteriostatic water and graduated syringes are sold separately and can be added to the same order.
Retatrutide is studied in metabolic research. Eli Lilly developed the molecule and has taken it from early work through large late-stage studies. In laboratory receptor assays it binds the GIP, GLP-1 and glucagon receptors. That triple target sets it apart from single-receptor GLP-1 analogues, which act at GLP-1 alone, and from dual GIP/GLP-1 agonists, which act at two.
The molecule is a single chain of 39 amino acids, built on a GIP peptide backbone. It carries a C20 fatty di-acid, meaning a twenty-carbon fatty group attached to the chain. That group is described as binding albumin in the blood, which is the design feature reported to make the molecule long-acting.
Australian Research Peptides supplies retatrutide as a freeze-dried solid, white to off-white, sealed in a tamper-evident glass vial. It is also written and searched as reta or retat. The material is a laboratory reference compound, characterised for work in glassware and cell culture rather than for any use in a living subject.
Content reviewed
Further reading: Where Is the Best Place to Buy Peptides in Australia?
Retatrutide 4-Vial Bundle specifications, storage and shipping
- Compound: Retatrutide 4-Vial Bundle
- Appearance: Four vials of white to off-white lyophilised powder, each sealed under a tamper-evident cap
- Sizes & SKUs: 4 × 10 mg vials (43729)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed to a minimum of 99% purity before release
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
